Literature DB >> 30442312

Update on Pathogenesis of Opisthorchiasis and Cholangiocarcinoma.

Banchob Sripa1, Sirikachorn Tangkawattana2, Paul J Brindley3.   

Abstract

Infection with the food-borne liver fluke Opisthorchis viverrini causes cholangiocarcinoma (CCA). Whereas the cause of CCA in the West remains obscure, the principal risk factor in Thailand is opisthorchiasis. Here, we review recent findings on the pathogenesis of opisthorchiasis and CCA focusing on helminth molecules/toxic metabolites, host-parasite interaction, endocytosis, immunopathology/inflammatory responses, free radical production, molecular genetic alterations, and multifactorial including coinfections driving to CCA development.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bile duct; Cholangiocarcinoma; Helicobacter; Immunopathology; Inflammation; Opisthorchiasis; Opisthorchis viverrini; Pathogenesis

Mesh：

Year:  2018        PMID： 30442312     DOI： 10.1016/bs.apar.2018.10.001

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN： 0065-308X            Impact factor:   3.125


  11 in total

Review 1.  Cholangiocarcinoma.

Authors:  Paul J Brindley; Melinda Bachini; Sumera I Ilyas; Shahid A Khan; Alex Loukas; Alphonse E Sirica; Bin Tean Teh; Sopit Wongkham; Gregory J Gores
Journal:  Nat Rev Dis Primers       Date:  2021-09-09       Impact factor: 65.038

Review 2.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

3.  Opisthorchis felineus infection provokes time-dependent accumulation of oxidative hepatobiliary lesions in the injured hamster liver.

Authors:  Mariya Y Pakharukova; Oxana G Zaparina; Yaroslav K Kapushchak; Nina V Baginskaya; Viatcheslav A Mordvinov
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

4.  Curcumin enhances chemotherapeutic effects and suppresses ANGPTL4 in anoikis-resistant cholangiocarcinoma cells.

Authors:  Tin Tin San; Prasong Khaenam; Virapong Prachayasittikul; Banchob Sripa; Nawapol Kunkeaw; Waraporn Chan-On
Journal:  Heliyon       Date:  2020-01-30

Review 5.  Control Strategies for Carcinogenic-Associated Helminthiases: An Integrated Overview.

Authors:  José Manuel Correia da Costa; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Júlio Santos; Lúcio Lara Santos
Journal:  Front Cell Infect Microbiol       Date:  2021-03-24       Impact factor: 6.073

Review 6.  Promising Technologies in the Field of Helminth Vaccines.

Authors:  Dilhan J Perera; Momar Ndao
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

7.  Risk Communication Through Health Beliefs for Preventing Opisthorchiasis-Linked Cholangiocarcinoma: A Community- Based Intervention in Multicultural Areas of Thailand.

Authors:  Nopparat Songserm; Pariwat Korsura; Somkiattiyos Woradet; Akhtar Ali
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

8.  Silencing of Opisthorchis viverrini Tetraspanin Gene Expression Results in Reduced Secretion of Extracellular Vesicles.

Authors:  Sujittra Chaiyadet; Javier Sotillo; Watchara Krueajampa; Sophita Thongsen; Michael Smout; Paul J Brindley; Thewarach Laha; Alex Loukas
Journal:  Front Cell Infect Microbiol       Date:  2022-02-11       Impact factor: 6.073

9.  Orally Administered Bacillus Spores Expressing an Extracellular Vesicle-Derived Tetraspanin Protect Hamsters Against Challenge Infection With Carcinogenic Human Liver Fluke.

Authors:  Wuttipong Phumrattanaprapin; Sujittra Chaiyadet; Paul J Brindley; Mark Pearson; Michael J Smout; Alex Loukas; Thewarach Laha
Journal:  J Infect Dis       Date:  2021-04-23       Impact factor: 5.226

10.  Omega-Class Glutathione Transferases of Carcinogenic Liver Fluke, Clonorchis sinensis, Modulate Apoptosis and Differentiation of Host Cholangiocytes.

Authors:  Chun-Seob Ahn; Jeong-Geun Kim; Insug Kang; Yoon Kong
Journal:  Antioxidants (Basel)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.